Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Treatment of hairy cell leukemia during pregnancy: are purine analogues and rituximab viable therapeutic options.

Literature DB >> 22981963

Treatment of hairy cell leukemia during pregnancy: are purine analogues and rituximab viable therapeutic options.

Naval Daver¹, Aziz Nazha, Hagop M Kantarjian, Rodney Haltom, Farhad Ravandi.

Abstract

Entities: Chemical Disease Gene Species

Mesh：

Substances：

Year: 2012 PMID： 22981963 PMCID： PMC4084644 DOI： 10.1016/j.clml.2012.06.009

Source DB: PubMed Journal: Clin Lymphoma Myeloma Leuk ISSN： 2152-2669

× No keyword cloud information.

29 in total

1. Rituximab as treatment for minimal residual disease in hairy cell leukaemia: extended follow-up.

Authors: Giulia Cervetti; Sara Galimberti; Francesca Andreazzoli; Rita Fazzi; Nadia Cecconi; Francesco Caracciolo; Mario Petrini
Journal: Br J Haematol Date: 2008-08-15 Impact factor: 6.998

2. Managing hairy cell leukemia in pregnancy.

Authors: A Alothman; T G Sparling
Journal: Ann Intern Med Date: 1994-06-15 Impact factor: 25.391

3. Rituximab, a chimaeric anti-CD20 monoclonal antibody, in the treatment of hairy cell leukaemia.

Authors: H Hagberg; L Lundholm
Journal: Br J Haematol Date: 2001-12 Impact factor: 6.998

4. Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA): long-term follow-up of the Northwestern University experience.

Authors: Punit Chadha; Alfred W Rademaker; Prateek Mendiratta; Benjamin Kim; Darren M Evanchuk; David Hakimian; LoAnn C Peterson; Martin S Tallman
Journal: Blood Date: 2005-03-10 Impact factor: 22.113

5. Treatment of hairy-cell leukemia with cladribine: response, toxicity, and long-term follow-up.

Authors: M A Hoffman; D Janson; E Rose; K R Rai
Journal: J Clin Oncol Date: 1997-03 Impact factor: 44.544

6. Relapse after interferon alfa-2b therapy for hairy-cell leukemia: analysis of prognostic variables.

Authors: M J Ratain; H M Golomb; J W Vardiman; C A Westbrook; C Barker; A Hooberman; M A Bitter; K Daly
Journal: J Clin Oncol Date: 1988-11 Impact factor: 44.544

7. Anti-CD20 treatment depletes B-cells in blood and lymphatic tissue of cynomolgus monkeys.

Authors: Carsten Schröder; Agnes M Azimzadeh; Guosheng Wu; James O Price; James B Atkinson; Richard N Pierson
Journal: Transpl Immunol Date: 2003 Oct-Nov Impact factor: 1.708

8. The role of rituximab in combination with pentostatin or cladribine for the treatment of recurrent/refractory hairy cell leukemia.

Authors: Monica Else; Nnenna Osuji; Francesco Forconi; Claire Dearden; Ilaria Del Giudice; Estella Matutes; Andrew Wotherspoon; Francesco Lauria; Daniel Catovsky
Journal: Cancer Date: 2007-11-15 Impact factor: 6.860

9. Exposure-disease continuum for 2-chloro-2'-deoxyadenosine (2-CdA), a prototype teratogen: induction of lumbar hernia in the rat and species comparison for the teratogenic responses.

Authors: Christopher Lau; Michael G Narotsky; Doris Lui; Deborah Best; R Woodrow Setzer; Peter C Mann; Judith A Wubah; Thomas B Knudsen
Journal: Teratology Date: 2002-07